Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3519-3525

  Brandt, Eric B ^a,b   Gibson, Aaron M ^a,b   Bass, Stacey ^a,b   Rydyznski, Carolyn ^a,b   Hershey, Gurjit K Khurana ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CALGRANULIN A; CXCL2 CHEMOKINE; INTERLEUKIN 17; INTERLEUKIN 17F; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; ATOPIC DERMATITIS; CONTROLLED STUDY; CUTANEOUS PARAMETERS; CXCL2 GENE; DISEASE COURSE; DISEASE EXACERBATION; ECZEMA; EPIDERMIS; EXPERIMENTAL MODEL; FEMALE; FUNCTIONAL DISEASE; IL 17A GENE; IL 17F GENE; IL 1BETA GENE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; S100A8 GENE; SENSITIZATION; SKIN EXAMINATION; SKIN FUNCTION; SKIN WATER LOSS; SKINFOLD THICKNESS; TNF ALPHA GENE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ALLERGENS; ANIMALS; ASPERGILLUS; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ECZEMA; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; SKIN; TOLL-LIKE RECEPTOR 4;

EID: 84885126380     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300789     Document Type: Article

References (46)

1. Williams, H., and C. Flohr. 2006. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J. Allergy Clin. Immunol. 118:209-213.
2. Kuo, I. H., T. Yoshida, A. De Benedetto, and L. A. Beck. 2013. The cutaneous innate immune response in patients with atopic dermatitis. J. Allergy Clin. Immunol. 131:266-278.
3. Barnes, K. C. 2010. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J. Allergy Clin. Immunol. 125:16-29. e1-11; quiz 30-31.
4. Fallon, P. G., T. Sasaki, A. Sandilands, L. E. Campbell, S. P. Saunders, N. E. Mangan, J. J. Callanan, H. Kawasaki, A. Shiohama, A. Kubo, et al. 2009. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat. Genet. 41:602-608.
5. Oyoshi, M. K., G. F. Murphy, and R. S. Geha. 2009. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J. Allergy Clin. Immunol. 124:485-493, 493.e1.
6. Boguniewicz, M., and D. Y. Leung. 2010. Recent insights into atopic dermatitis and implications for management of infectious complications. J. Allergy Clin. Immunol. 125:4-13; quiz 14-15.
7. Miller, L. S., and R. L. Modlin. 2007. Toll-like receptors in the skin. Semin. Immunopathol. 29:15-26.
8. Howell, M. D., B. E. Kim, P. Gao, A. V. Grant, M. Boguniewicz, A. De Benedetto, L. Schneider, L. A. Beck, K. C. Barnes, and D. Y. Leung. 2009. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 124(Suppl. 2):R7-R12.
9. Ahmad-Nejad, P., S. Mrabet-Dahbi, K. Breuer, M. Klotz, T. Werfel, U. Herz, K. Heeg, M. Neumaier, and H. Renz. 2004. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J. Allergy Clin. Immunol. 113:565-567.
10. Miller, L. S., R. M. O'Connell, M. A. Gutierrez, E. M. Pietras, A. Shahangian, C. E. Gross, A. Thirumala, A. L. Cheung, G. Cheng, and R. L. Modlin. 2006. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24:79-91.
11. An, Y., H. Ohnishi, E. Matsui, M. Funato, Z. Kato, T. Teramoto, H. Kaneko, T. Kimura, K. Kubota, K. Kasahara, and N. Kondo. 2011. Genetic variations in MyD88 adaptor-like are associated with atopic dermatitis. Int. J. Mol. Med. 27:795-801.
12. Novak, N., C. F. Yu, C. Bussmann, L. Maintz, W. M. Peng, J. Hart, T. Hagemann, A. Diaz-Lacava, H. J. Baurecht, N. Klopp, et al. 2007. Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 62:766-772.
13. Lange, J., A. Heinzmann, C. Zehle, and M. Kopp. 2005. CT genotype of promotor polymorphism C159T in the CD14 gene is associated with lower prevalence of atopic dermatitis and lower IL-13 production. Pediatr. Allergy Immunol. 16:456-457.
14. Grice, E. A., H. H. Kong, S. Conlan, C. B. Deming, J. Davis, A. C. Young, G. G. Bouffard, R. W. Blakesley, P. R. Murray, E. D. Green, et al.; NISC Comparative Sequencing Program. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324:1190-1192.
15. Scharschmidt, T C, K. List, E. A. Grice, R. Szabo, G. Renaud, C. C. Lee, T. G. Wolfsberg, T. H. Bugge, and J. A. Segre; NISC Comparative Sequencing Program. 2009. Matriptase-deficient mice exhibit ichthyotic skin with a selective shift in skin microbiota. J. Invest. Dermatol. 129:2435-2442.
16. Scharschmidt, T. C, M. Q. Man, Y. Hatano, D. Crumrine, R. Gunathilake, J. P. Sundberg, K. A. Silva, T. M. Mauro, M. Hupe, S. Cho, et al. 2009. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J. Allergy Clin. Immunol. 124:496-506, 506. e1-6.
17. Penders, J., C. Thijs, M. Mommers, E. E. Stobberingh, E. Dompeling, N. E. Reijmerink, P. A. van den Brandt, M. Kerkhof, G. H. Koppelman, and D. S. Postma. 2010. Host-microbial interactions in childhood atopy: Toll-like receptor 4(TLR4), CD14, and fecal Escherichia coli. J. Allergy Clin. Immunol. 125:231-236. e1-5.
18. Grigoryev, D. N., M. D. Howell, T. N. Watkins, Y. C. Chen, C. Cheadle, M. Boguniewicz, K. C. Barnes, and D. Y Leung. 2010. Vaccinia virus-specific molecular signature in atopic dermatitis skin. J. Allergy Clin. Immunol. 125:153-159. e28.
19. Kagan, J. C, T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. Nat. Immunol. 9:361-368.
20. Zanoni, I., R. Ostuni, L. R. Marek, S. Barresi, R. Barbalat, G. M. Barton, F. Granucci, and J. C. Kagan. 2011. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147:868-880.
21. Lebre, M. C, A. M. van der Aar, L. van Baarsen, T. M. van Capel, J. H. Schuitemaker, M. L. Kapsenberg, and E. C. de Jong. 2007. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127:331-341.
22. Sivaprasad, U., M. R. Warrier, A. M. Gibson, W. Chen, Y. Tabata, S. A. Bass, M. E. Rothenberg, and G. K. Khurana Hershey. 2010. IL-13Ra2 has a protective role in a mouse model of cutaneous inflammation. J. Immunol. 185:6802-6808.
23. Leder, L. D. 1979. The chloroacetate esterase reaction: a useful means of histological diagnosis of hematological disorders from paraffin sections of skin. Am. J. Dermatopathol. 1:39-42.
24. Gupta, J., E. Grube, M. B. Ericksen, M. D. Stevenson, A. W. Lucky, A. P. Sheth, A. H. Assa'ad, and G. K. Khurana Hershey. 2008. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J. Allergy Clin. Immunol. 121:725-730. e2.
25. Oyoshi, M. K., R. He, L. Kumar, J. Yoon, and R. S. Geha. 2009. Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol. 102:135-226.
26. Yoo, J., M. Omori, D. Gyarmati, B. Zhou, T. Aye, A. Brewer, M. R. Comeau, D. J. Campbell, and S. F. Ziegler. 2005. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 202:541-549.
27. He, R., M. K. Oyoshi, L. Garibyan, L. Kumar, S. F. Ziegler, and R. S. Geha. 2008. TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc. Natl. Acad. Sci. USA 105:11875-11880.
28. Comeau, M. R., and S. F. Ziegler. 2010. The influence of TSLP on the allergic response. Mucosal Immunol. 3:138-147.
29. Kezic, S., G. M. O'Regan, R. Lutter, I. Jakasa, E. S. Koster, S. Saunders, P. Caspers, P. M. Kemperman, G. J. Puppels, A. Sandilands, et al. 2012. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J. Allergy Clin. Immunol. 129:1031-1039. e1.
30. Brandt, E. B., and U. Sivaprasad. 2011. Th2 cytokines and atopic dermatitis. J. Clin. Cell Immunol. 2: pii: 110.
31. Kim, B. S., M. C. Siracusa, S. A. Saenz, M. Noti, L. A. Monticelli, G. F. Sonnenberg, M. R. Hepworth, A. S. Van Voorhees, M. R. Comeau, and D. Artis. 2013. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci. Transl. Med. 5:170ra16.
32. Johnston, A., Y. Fritz, S. M. Dawes, D. Diaconu, P. M. Al-Attar, A. M. Guzman, C. S. Chen, W. Fu, J. E. Gudjonsson, T. S. McCormick, and N. L. Ward. 2013. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J. Immunol. 190:2252-2262.
33. Ehrchen, J. M., C. Sunderkötter, D. Foell, T. Vogl, and J. Roth. 2009. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 86:557-566.
34. He, R., M. K. Oyoshi, H. Jin, and R. S. Geha. 2007. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc. Natl. Acad. Sci. USA 104:15817-15822.
35. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27:485-517.
36. Bernard, J. J., C. Cowing-Zitron, T. Nakatsuji, B. Muehleisen, J. Muto, A. W. Borkowski, L. Martinez, E. L. Greidinger, B. D. Yu, and R. L. Gallo. 2012. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat. Med. 18:1286-1290.
37. Hoebe, K., E. M. Janssen, S. O. Kim, L. Alexopoulou, R. A. Flavell, J. Han, and B. Beutler. 2003. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trifindependent pathways. Nat. Immunol. 4:1223-1229.
38. Weighardt, H., G. Jusek, J. Mages, R. Lang, K. Hoebe, B. Beutler, and B. Holzmann. 2004. Identification of a TLR4-and TRIF-dependent activation program of dendritic cells. Eur. J. Immunol. 34:558-564.
39. Shen, H., B. M. Tesar, W. E. Walker, and D. R. Goldstein. 2008. Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J. Immunol. 181:1849-1858.
40. Jin, H., L. Kumar, C. Mathias, D. Zurakowski, H. Oettgen, L. Gorelik, and R. Geha. 2009. Toll-like receptor 2 is important for the T (H) 1 response to cutaneous sensitization. J. Allergy Clin. Immunol. 123:875-882.e1.
41. Chen, L., S. Guo, M. J. Ranzer, and L. A. Di Pietro. 2013. Toll-like receptor 4 has an essential role in early skin wound healing. J. Invest. Dermatol. 133:258-267.
42. Lin, Q., D. Fang, J. Fang, X. Ren, X. Yang, F. Wen, and S. B. Su. 2011. Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice. J. Immunol. 186:3710-3717.
43. Koff, J. L., M. X. Shao, S. Kim, I. F. Ueki, and J. A. Nadel. 2006. Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J. Immunol. 177:8693-8700.
44. Jeong, S. K., H. J. Kim, J. K. Youm, S. K. Ahn, E. H. Choi, M. H. Sohn, K. E. Kim, J. H. Hong, D. M. Shin, and S. H. Lee. 2008. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J. Invest. Dermatol. 128:1930-1939.
45. Trompette, A., S. Divanovic, A. Visintin, C. Blanchard, R. S. Hegde, R. Madan, P. S. Thorne, M. Wills-Karp, T. L. Gioannini, J. P. Weiss, and C. L. Karp. 2009. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457:585-588.
46. Eisenbarth, S. C., A. Zhadkevich, P. Ranney, C. A. Herrick, and K. Bottomly. 2004. IL-4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88. J. Immunol. 172:4527-4534.